Cargando…
Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis
The development of a new vaccine as a substitute for Bacillus Calmette–Guerin or to improve its efficacy is one of the many World Health Organization goals to control tuberculosis. Mycobacterial vectors have been used successfully in the development of vaccines against tuberculosis. To enhance the p...
Autores principales: | Junqueira-Kipnis, Ana Paula, de Oliveira, Fábio Muniz, Trentini, Monalisa Martins, Tiwari, Sangeeta, Chen, Bing, Resende, Danilo Pires, Silva, Bruna D. S., Chen, Mei, Tesfa, Lydia, Jacobs, William R., Kipnis, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826754/ https://www.ncbi.nlm.nih.gov/pubmed/24250805 http://dx.doi.org/10.1371/journal.pone.0078639 |
Ejemplares similares
-
Immunogenicity of a Recombinant Mycobacterium smegmatis
Vaccine Expressing the Fusion Protein CMX in Cattle from Goiás State,
Brazil
por: ALVES DA SILVA, Duanne, et al.
Publicado: (2014) -
The mc(2)-CMX vaccine induces an enhanced immune response
against Mycobacterium tuberculosis compared to Bacillus
Calmette-Guérin but with similar lung inflammatory effects
por: de Oliveira, Fábio Muniz, et al.
Publicado: (2016) -
Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against Mycobacterium massiliensis
por: Marques-Neto, Lázaro M., et al.
Publicado: (2018) -
Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2022) -
Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection
por: de Sousa, Eduardo Martins, et al.
Publicado: (2012)